Zsuzsanna Lonovics

Title: Zsuzsanna Lonovics: Innovator in Pharmaceutical Composition

Introduction

Zsuzsanna Lonovics is a notable inventor based in Taszar, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that protect against oxidative and toxic substances. Her work is especially relevant in the context of cardiotoxicity, which can arise from certain medications and chemicals.

Latest Patents

Zsuzsanna holds a patent for a pharmaceutical composition designed to provide protective action against oxidative and toxic substances, particularly cardiotoxic agents. The patent details the use of benzazepin-N-acetic acid derivatives that contain an oxo group in the a position to the nitrogen atom. These compounds are substituted in the 3 position by a 1-(carboxyalkyl)-cyclopentyl-carbonyl-amino radical, along with their salts and biolabile esters. This invention is aimed at the prophylaxis and treatment of heart damage caused by cardiotoxic doses of medications or chemicals, particularly during cytostatic chemotherapy.

Career Highlights

Zsuzsanna is associated with Solvay Pharmaceuticals GmbH, where she has been able to apply her innovative ideas in a professional setting. Her work has the potential to significantly impact the treatment of heart damage in larger mammals, especially humans.

Collaborations

Zsuzsanna has collaborated with notable colleagues such as Julius Gy Papp and Dirk Thormaehlen. These partnerships have likely contributed to the advancement of her research and the successful development of her patented compositions.

Conclusion

Zsuzsanna Lonovics is a pioneering inventor whose work in pharmaceutical compositions addresses critical health challenges related to cardiotoxicity. Her innovative contributions continue to pave the way for advancements in medical treatments.